Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAUTERINEStandard

LILETTA

LEVONORGESTREL

Standard Dose
52MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LILETTA is listed in Drugs@FDA under application 206229 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LEVONORGESTREL Form and strength SYSTEM;INTRAUTERINE - 52MG Sponsor MEDICINES360 Submission history Latest submission status date: 2023-06-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview LILETTA is listed in Drugs@FDA under application 206229 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEVONORGESTREL Form and strength SYSTEM;INTRAUTERINE - 52MG Sponsor MEDICINES360 Submission history Latest submission status date: 2023-06-29 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
LILETTA (LEVONORGESTREL) | Drug Monograph | MedicHelpline